Immundiagnostik, Inc., a leading provider of immunoassays and lab detection tools, is excited to announce its upcoming exhibition at the 2025 ADLM Clinical Lab Expo in Chicago, July 29–31. Attendees are invited to visit booth #2240 to experience live demonstrations of two powerful innovations for high-throughput laboratories: the ECL100 Chemiluminescent Immunoassay Analyzer and the QSE180 Autosampler.
Developed by Epitope Diagnostics, Inc., the ECL100 and QSE180 are designed to work separately or in tandem to help streamline stool sample testing, offering unmatched automation, efficiency, and scalability for labs across North America.
The ECL100 is a fully automated chemiluminescent immunoassay analyzer that delivers:
The QSE180 automates stool sample preparation for vital CLIA tests including calprotectin, pancreatic elastase-1 (PE-1), quantitative fecal occult blood (qFOB), and H. pylori. Key features include:
“By providing the ECL100 and QSE180, we’re bringing next-generation automation and assay compatibility to high-throughput labs in North America,” said Terry Fisher, Chief Operations Officer at Immundiagnostik, Inc. “Whether used together or separately, these innovative tools offer a powerful, cost-effective solution to increase efficiency and reduce hands-on time, all without sacrificing precision.”
Attendees of the 2025 ADLM Clinical Lab Expo are encouraged to stop by booth 2240 to discover more about Immundiagnostik, Inc.’s full menu of CLIA assays, see live instrument demonstrations, and speak with experts from both Immundiagnostik and Epitope Diagnostics, Inc.
To schedule a demo or meeting in advance, please contact Immundiagnostik, Inc. via email: idkinc@immundiagnostik.com.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
